[go: up one dir, main page]

MX2023003033A - Compuestos y metodos para el tratamiento de infecciones por virus. - Google Patents

Compuestos y metodos para el tratamiento de infecciones por virus.

Info

Publication number
MX2023003033A
MX2023003033A MX2023003033A MX2023003033A MX2023003033A MX 2023003033 A MX2023003033 A MX 2023003033A MX 2023003033 A MX2023003033 A MX 2023003033A MX 2023003033 A MX2023003033 A MX 2023003033A MX 2023003033 A MX2023003033 A MX 2023003033A
Authority
MX
Mexico
Prior art keywords
compounds
virus infections
treating virus
treating
metabolite
Prior art date
Application number
MX2023003033A
Other languages
English (en)
Inventor
Marc Salome
Xavier Maniere
Original Assignee
Meletios Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meletios Therapeutics filed Critical Meletios Therapeutics
Publication of MX2023003033A publication Critical patent/MX2023003033A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un compuesto de la siguiente fórmula (I): (ver Fórmula) (I) o una sal, éster, hidrato, derivado, profármaco o metabolito farmacéuticamente aceptable del mismo para usar en la prevención o el tratamiento de una infección por un virus en un individuo. (sin figura).
MX2023003033A 2020-09-17 2021-09-17 Compuestos y metodos para el tratamiento de infecciones por virus. MX2023003033A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306048 2020-09-17
EP21305200 2021-02-18
PCT/EP2021/075679 WO2022058533A1 (en) 2020-09-17 2021-09-17 Compounds for treating virus infections

Publications (1)

Publication Number Publication Date
MX2023003033A true MX2023003033A (es) 2023-06-09

Family

ID=77951710

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023003033A MX2023003033A (es) 2020-09-17 2021-09-17 Compuestos y metodos para el tratamiento de infecciones por virus.

Country Status (12)

Country Link
US (1) US20230364033A1 (es)
EP (1) EP4213822A1 (es)
JP (1) JP2023541960A (es)
KR (1) KR20230069132A (es)
CN (1) CN116437960A (es)
AU (1) AU2021342704A1 (es)
CA (1) CA3192518A1 (es)
CL (1) CL2023000731A1 (es)
CO (1) CO2023004589A2 (es)
IL (1) IL300858A (es)
MX (1) MX2023003033A (es)
WO (1) WO2022058533A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1475314A (en) 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
JPH022116A (ja) * 1988-06-15 1990-01-08 Toshiba Corp 半導体装置の製造方法
FR2641276B1 (fr) * 1988-12-30 1991-07-12 Sanofi Sa Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant
FR2663328B1 (fr) 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2694287B1 (fr) 1992-07-31 1994-09-16 Jouveinal Inst Rech Nouvelles cycloalkylalkylamines ligands aux récepteurs sigma, leur procédé de préparation et leur application en thérapeutique.
FR2713639B1 (fr) 1993-12-09 1996-08-30 Irj Nouveaux dérivés de 2-arylalkényl-azacycloalkanes ligands aux récepteurs sigma, leur procédé de préparation et leur application en thérapeutique.
FR2724656B1 (fr) 1994-09-15 1996-12-13 Adir Nouveaux derives du benzopyranne, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2725445B1 (fr) 1994-10-10 1996-10-31 Adir Nouveaux derives a structure 1-arylalkenyl 4-aryl alkyl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
CN1990479A (zh) * 2005-12-29 2007-07-04 中国科学院上海药物研究所 3－烷氧取代－2,5,7－三取代苯并吡喃－4－酮类化合物及其制备方法和包含该类化合物的药物组合物
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2019053696A1 (en) * 2017-09-18 2019-03-21 Alios Biopharma, Inc. SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
US20230190684A1 (en) * 2020-03-16 2023-06-22 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound

Also Published As

Publication number Publication date
KR20230069132A (ko) 2023-05-18
AU2021342704A9 (en) 2024-04-18
CA3192518A1 (en) 2022-03-24
AU2021342704A1 (en) 2023-05-04
IL300858A (en) 2023-04-01
JP2023541960A (ja) 2023-10-04
CN116437960A (zh) 2023-07-14
US20230364033A1 (en) 2023-11-16
EP4213822A1 (en) 2023-07-26
CL2023000731A1 (es) 2023-11-24
WO2022058533A1 (en) 2022-03-24
CO2023004589A2 (es) 2023-04-27

Similar Documents

Publication Publication Date Title
PH12022553378A1 (en) Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
CR20240147A (es) Uso de un inhibidor de la ezh2 en la preparación de fármacos para el tratamiento del linfoma de linfocitos t
PH12018500147A1 (en) Benzodiazepine derivatives as rsv inhibitors
PH12022550783A1 (en) Antiviral heterocyclic compounds
WO2017123884A8 (en) Heterocyclic compounds as rsv inhibitors
SA521431048B1 (ar) مركبات بيروليدين
CL2024000067A1 (es) Compuestos antivirales
PH12019501198A1 (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
PH12021552201A1 (en) Benzodiazepine derivatives as rsv inhibitors
PH12021552482A1 (en) Compounds targeting prmt5
PH12020550107A1 (en) Chromane monobactam compounds for the treatment of bacterial infections
MX2010007375A (es) Nuevos derivados de lupano.
MX2009012418A (es) Derivados de quinazolin-oxima como inhibidores de hsp90.
MX2020011317A (es) Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih.
SA523451905B1 (ar) Cdk2 مركبات بيريميدينيل-بيرازول بها استبدال كمثبطات
UY27577A1 (es) Inhibidores de la integrasa del vih
MY207239A (en) Imidazopyridinone compound
AU2020353055A8 (en) Antiviral pyrazolopyridinone compounds
NZ758839A (en) Glycopeptide derivative compounds and uses thereof
MX384745B (es) Proceso para la preparación de compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidina-2,7-diona 3-sustituidos.
WO2020096916A3 (en) Inhibitors of histone deacetylase useful for the treatment or prevention of hiv infection
JOP20210353A1 (ar) مركبات وطرق استخدامها كعوامل مضادة للجراثيم
GEAP202516217A (en) Compounds and compositions as sppl2a inhibitors
MX2023003033A (es) Compuestos y metodos para el tratamiento de infecciones por virus.
WO2020251871A3 (en) Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors